TG 100713

TG 1713,3-(2,4-DIAMINO-6-PTERIDINYL)-PHENOL

TG100713;TG 100713;CS-577;TG100110

E-7050 (Golvatinib)

N-[2-氟-4-[[2-[[[4-(4-甲基哌嗪-1-基)哌啶-1-基]羰基]氨基]吡啶-4-基]氧基]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺

N-[2-氟-4-[[2-[[[4-(4-甲基哌嗪-1-基)哌啶-1-基]羰基]氨基]吡啶-4-基]氧基]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺;戈伐替尼

GNF 2

3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺

GNF2;GNF 2;3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺;3-(6-(4-(TRIFLUOROMETHOXY)PHENYLAMINO)PYRIMIDIN-4-YL)BENZAMIDE

TDZD-8

4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE

4-苄基-2-甲基-1,2,4-噻二唑烷-3,5-二酮;4-苯甲基-2-甲基-1,5-二酮

L 2-401

4-[(4-氟苯基)甲基]-2-(4-甲基苯基)-1,2,4-噻二唑烷-3,5-二酮

CS-563;CCG50014;CCG 50014;4-[(4-氟苯基)甲基]-2-(4-甲基苯基)-1,2,4-噻二唑烷-3,5-二酮

AZD5363

4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺

CS-561;AZD-5363;AZD 5363;CAPIVASERTIB (AZD5363);4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺;AZD5363;AZD-5363;AZD 5363;AZD5363,一种有效的 PAN-AKT 激酶抑制剂

duloxetine

度洛西汀

(S)-N-甲基-Γ-(1-萘氧基)-2-噻吩丙胺;(S)-N-甲基-3-(萘-1-基氧)-3-(噻吩-2-基)丙烷-1-胺;多罗西汀;度洛西丁;度洛西汀(多罗西汀);(S)-(+)-N-甲基-3-(1-萘氧基)-3-(3-噻吩)-丙胺;度洛西汀

N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide

N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氢-3-吡啶甲酰胺

CS-557;N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氢-3-吡啶甲酰胺

patupilone

埃博霉素B

帕土匹龙(埃坡霉素 B、埃坡西龙 B、埃博霉素B、爱博霉素B);(1S,3S,7S,10R,11S,12S,16R)-7,11-二羟基-8,8,10,12,16-五甲基-3-[(1E)-1-甲基-2-(2-甲基-4-噻唑基)乙烯基]-4,17-二氧杂双环[14.1.0]十七烷-5,10-二酮;埃坡霉素 B;帕土匹龙;埃博霉素B;(-)-埃博霉素B;帕妥匹隆

Epothilone A

埃博霉素 A

伊沙匹隆杂质;伊沙匹隆杂质5;埃博霉素 A;埃博霉素 A(埃坡西龙 A、埃博霉素A、爱博霉素A);埃坡西龙 A;埃坡霉素A

ON-01910

N-[2-甲氧基-5-[[[2-(2,4,6-三甲氧基苯基)乙烯基]磺酰]甲基]苯基]甘氨酸钠盐

CS-551;N-[2-甲氧基-5-[[[2-(2,4,6-三甲氧基苯基)乙烯基]磺酰]甲基]苯基]甘氨酸钠盐;ON 01910 钠盐;ON-01910;ESTYBON;ON-01910;ON01910;ON 01910

lopinavir

洛匹那韦

匹洛那韦;洛比那韦;洛匹那韦 LOPINAVIR;罗平拉韦;洛匹那韦(标准品);(2S)-N-[(2R,4S,5S)-5-[[2-(2,6-二甲基苯氧基)乙酰]氨基]-4-羟基-1,6-二苯基-己-2-基]-3-甲基-2-(2-氧代-1,3-二氮杂环己-2-基)丁酰胺;洛匹那韦

MK-5108 (VX-689)

MK-518 (VX-689)

CS-545;MK 5108;VX-689;VX 689;MK5108;VX689;反式-4-(3-氯-2-氟苯氧基)-1-[[6-(2-噻唑基氨基)-2-吡啶基]甲基]环己烷甲酸

CH5132799

[5-[7-甲磺酰基-2-(吗啉-4-基)-6,7-二氢-5H-吡咯并[2,3-D]嘧啶-4-基]嘧啶-2-基]胺

CS-541;[5-[7-甲磺酰基-2-(吗啉-4-基)-6,7-二氢-5H-吡咯并[2,3-D]嘧啶-4-基]嘧啶-2-基]胺;CS-1068;CH5132799;CH 5132799;CH-5132799

WYE-687

N-[4-[4-(4-吗啉基)-1-[1-(3-吡啶甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]氨基甲酸甲酯

CS-540;N-[4-[4-(4-吗啉基)-1-[1-(3-吡啶甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]氨基甲酸甲酯;WYE-687;WYE 687;WYE687

GSK1059615

(5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮

(5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮;(Z)-5-((4-(吡啶-4-基)喹啉-6-基)亚甲基)噻唑烷-2,4-二酮

atazanavir

阿扎那韦

硫酸他扎那韦;BMS-232632-05;REYATAZ;BMS23263205;CS-2210;阿扎那韦对映异构体;阿扎那韦手性异构体;阿扎那韦手性异构体1;阿扎那韦手性异构体2;CS-534;阿扎那韦手性异构体4

DCC-2036 (Rebastinib)

N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲

N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲;DCC2036;DCC 2036;CS-1867

PD04217903

2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-基]乙醇

PD04217903;2-[4-[1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl]-1H-pyrazol-1-yl]ethanol;2-(4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-1H-pyrazol-1-yl)ethanol;2-[4-[1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl]-1H-pyrazol-1-yl]ethanol PF 04217903;PF 04217903 2-[4-[1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl]-1H-pyrazol-1-yl]ethanol;2-{4-[1-(6-Quinolinylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-y l]-1H-pyrazol-1-yl}ethanol;2-[4-[3-(quinolin-6-ylmethyl)triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol

Gefitinib

吉非替尼

格非替尼;N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺;吉非替尼;易瑞沙(阿斯利康公司的抗肿瘤新药);易瑞沙(吉非替尼);N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-5-胺、吉菲替尼、易瑞沙;吉非替尼原料药;吉非替尼(易瑞沙);吉菲替尼;吉非替尼